Description

Greenberg Traurig’s Health Care & FDA Practice invites you to join a two part webinar series on the End of the COVID-19 Public Health Emergency

Webinar One
End of the COVID Public Health Emergency: What This Means for FDA-Regulated Companies and Next Steps

Tuesday, March 21, 2023
11:00 a.m. – 12:00 p.m. (CT)

In this webinar, we will cover upcoming regulatory and business changes associated with the end of the COVID-19 public health emergency (PHE) which is currently scheduled to take place on May 11, 2023. We will discuss the changes and impacts on FDA regulated entities, including:

• Waivers within the FDA that are impacted and affect
  each FDA center, including the following key issues: 
• Changes to food labeling and other food related issues
• Changes to certain Emergency Use Authorizations (EUA)
  for drugs, vaccines and testing and other COVID-19 related issues
• Lessons learned by the FDA and HHS for future pandemics

Webinar Two
End of the COVID Public Health Emergency: Consequences and Recommendations for Providers

Monday, March 27, 2023
12:oo p.m. – 1:00 p.m. (CT

In this webinar, we will cover upcoming regulatory and business changes associated with the end of the COVID-19 public health emergency (PHE), which is currently scheduled to take place on May 11, 2023. Among the changes for providers we will discuss are:

• Changes to Medicaid coverage and flexibilities
• Changes to coverage and costs associated with COVID-19 testing, treatment and vaccines as well as other private insurance changes
• Changes to telehealth flexibilities

CLICK HERE TO REGISTER